Literature DB >> 17367492

Incidence and mortality of venous thrombosis: a population-based study.

I A Naess1, S C Christiansen, P Romundstad, S C Cannegieter, F R Rosendaal, J Hammerstrøm.   

Abstract

BACKGROUND: Estimates of the incidence of venous thrombosis (VT) vary, and data on mortality are limited.
OBJECTIVES: We estimated the incidence and mortality of a first VT event in a general population.
METHODS: From the residents of Nord-Trøndelag county in Norway aged 20 years and older (n = 94 194), we identified all cases with an objectively verified diagnosis of VT that occurred between 1995 and 2001. Patients and diagnosis characteristics were retrieved from medical records.
RESULTS: Seven hundred and forty patients were identified with a first diagnosis of VT during 516,405 person-years of follow-up. The incidence rate for all first VT events was 1.43 per 1000 person-years [95% confidence interval (CI): 1.33-1.54], that for deep-vein thrombosis (DVT) was 0.93 per 1000 person-years (95% CI: 0.85-1.02), and that for pulmonary embolism (PE) was 0.50 per 1000 person-years (95% CI: 0.44-0.56). The incidence rates increased exponentially with age, and were slightly higher in women than in men. The 30-day case-fatality rate was higher in patients with PE than in those with DVT [9.7% vs. 4.6%, risk ratio 2.1 (95% CI: 1.2-3.7)]; it was also higher in patients with cancer than in patients without cancer [19.1% vs. 3.6%, risk ratio 3.8 (95% CI 1.6-9.2)]. The risk of dying was highest in the first months subsequent to the VT, after which it gradually approached the mortality rate in the general population.
CONCLUSIONS: This study provides estimates of incidence and mortality of a first VT event in the general population.

Entities:  

Mesh:

Year:  2007        PMID: 17367492     DOI: 10.1111/j.1538-7836.2007.02450.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  302 in total

Review 1.  Acute pulmonary embolism. Part 1: epidemiology and diagnosis.

Authors:  Renée A Douma; Pieter W Kamphuisen; Harry R Büller
Journal:  Nat Rev Cardiol       Date:  2010-07-20       Impact factor: 32.419

Review 2.  5th International ACC Symposium: Old Syndromes with New Biomarkers and New Therapies with Old Medications.

Authors:  Sarika N Rao; Mouhammed Amir Habra
Journal:  Horm Cancer       Date:  2015-12-10       Impact factor: 3.869

3.  A Case of Duodenal Resection and Duodenojejunostomy for Multiple Small Bowel Infarction in Patient With Inherited Thrombophilia and Vitamin K Antagonist Induced Critical Hypocoagulation.

Authors:  Badri Kobalava; Anzor Kvashilava; Giorgi Giorgobiani; Irina G Datikashvili-David; Nana Turava
Journal:  Cureus       Date:  2021-02-04

Review 4.  Oral contraceptives and venous thromboembolism: a systematic review and meta-analysis.

Authors:  Lamberto Manzoli; Corrado De Vito; Carolina Marzuillo; Antonio Boccia; Paolo Villari
Journal:  Drug Saf       Date:  2012-03-01       Impact factor: 5.606

Review 5.  Venous thromboembolism: Predicting recurrence and the need for extended anticoagulation.

Authors:  Geoffrey D Barnes; Yogendra Kanthi; James B Froehlich
Journal:  Vasc Med       Date:  2015-04       Impact factor: 3.239

Review 6.  Venous thromboembolism prophylaxis with unfractionated heparin in the hospitalized medical patient: the case for thrice daily over twice daily dosing.

Authors:  Charles E Mahan; Mario Pini; Alex C Spyropoulos
Journal:  Intern Emerg Med       Date:  2010-02-23       Impact factor: 3.397

7.  Pulmonary embolism in patients with transvenous cardiac implantable electronic device leads.

Authors:  Amit Noheria; Shiva P Ponamgi; Christopher V Desimone; Vaibhav R Vaidya; Christopher A Aakre; Elisa Ebrille; Tiffany Hu; David O Hodge; Joshua P Slusser; Naser M Ammash; Charles J Bruce; Alejandro A Rabinstein; Paul A Friedman; Samuel J Asirvatham
Journal:  Europace       Date:  2015-03-12       Impact factor: 5.214

8.  In-hospital left ventricular thrombus following ST-elevation myocardial infarction.

Authors:  Aiham Albaeni; Khaled Chatila; Hind A Beydoun; May A Beydoun; Mohammad Morsy; Wissam I Khalife
Journal:  Int J Cardiol       Date:  2019-07-23       Impact factor: 4.164

9.  Different risk of deep vein thrombosis and pulmonary embolism in carriers with factor V Leiden compared with non-carriers, but not in other thrombophilic defects. Results from a large retrospective family cohort study.

Authors:  Anja B U Mäkelburg; Nic J G M Veeger; Saskia Middeldorp; Karly Hamulyák; Martin H Prins; Harry R Büller; Willem M Lijfering
Journal:  Haematologica       Date:  2009-12-08       Impact factor: 9.941

Review 10.  Risk of venous thromboembolism among patients with vasculitis: a systematic review and meta-analysis.

Authors:  Patompong Ungprasert; Matthew J Koster; Charat Thongprayoon; Kenneth J Warrington
Journal:  Clin Rheumatol       Date:  2016-08-30       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.